0001209191-19-025415.txt : 20190419 0001209191-19-025415.hdr.sgml : 20190419 20190419214159 ACCESSION NUMBER: 0001209191-19-025415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180305 FILED AS OF DATE: 20190419 DATE AS OF CHANGE: 20190419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Long Andrew G CENTRAL INDEX KEY: 0001714880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 19758446 MAIL ADDRESS: STREET 1: 1333 SOUTH SPECTRUM BLVD, SUITE 100 CITY: CHANDLER STATE: AZ ZIP: 85286 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-05 0 0001516479 Insys Therapeutics, Inc. INSY 0001714880 Long Andrew G 1333 S SPECTRUM BLVD #100 CHANDLER AZ 85286 0 1 0 0 Chief Financial Officer Common Stock 2018-03-05 4 A 0 10600 0.00 A 20600 D Common Stock 2019-01-25 4 A 0 29000 0.00 A 49600 D Employee Stock Option (right to buy) 8.06 2018-03-05 4 A 0 42400 0.00 A 2028-03-04 Common Stock 42400 42400 D Employee Stock Option (right to buy) 3.81 2019-01-25 4 A 0 173000 0.00 A 2029-01-24 Common Stock 173000 173000 D The total reported in Column 5 includes 15,000 RSUs previously reported in Table II on the Form 4 filed 8/17/17. The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 5, 2022. The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023. /s/ Andrew Long 2019-04-19